ABBOTT LABS - N. CHICAGO PLANT | AbbVie | environmental violation | 2006 | EPA | $475,672 |
Alpharma Inc. (Chicago Heights) | Zoetis | environmental violation | 2006 | EPA | $29,737 |
ELI LILLY AND COMPANY | Eli Lilly | environmental violation | 2011 | EPA | $337,500 |
Phibro-Tech, Inc. | Phibro Animal Health | environmental violation | 2008 | EPA | $151,603 |
ELI LILLY & COMPANY - TIPPECANOE LABS | Eli Lilly | environmental violation | 2009 | EPA | $12,000 |
ABBOTT LABS - N. CHICAGO PLANT | AbbVie | environmental violation | 2011 | EPA | $135,756 |
CSL Behring LLC | CSL Limited | environmental violation | 2015 | EPA | $62,780 |
ACTAVIS,INC. | AbbVie | environmental violation | 2015 | EPA | $30,800 |
Pharmacia and Upjohn Company LLC | Pfizer | environmental violation | 2017 | EPA | $34,170 |
Aldrich Chemical | Merck KGaA (EMD) | environmental violation | 2018 | EPA | $5,000 |
Aldrich Chemical, LLC | Merck KGaA (EMD) | environmental violation | 2018 | EPA | $5,000 |
KREMERS URBAN PHARMACEUTICALS INC | Lannett Co. | environmental violation | 2018 | EPA | $285,000 |
CSL BEHRING LLC | CSL Limited | environmental violation | 2021 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $527,144 |
MALLINCKRODT, INC | Mallinckrodt | environmental violation | 2004 | EPA | $80,160 |
CAMBREX CHARLES CITY, INC | Cambrex | environmental violation | 2006 | EPA | $106,749 |
SIGMA ALDRICH MFG LLC | Merck KGaA (EMD) | environmental violation | 2007 | EPA | $55,000 |
ABBOTT LABORATORIES | Abbott Laboratories | environmental violation | 2008 | EPA | $25,033 |
TEVA PHARMACEUTICALS USA INC | Teva Pharmaceutical Industries | environmental violation | 2013 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,250,000 |
BOEHRINGER INGELHEIM VETMEDICA, INC | Eli Lilly | environmental violation | 2011 | EPA | $900,000 |
BOEHRINGER INGELHEIM VETMEDICA, INC | Eli Lilly | environmental violation | 2012 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $338,475 |
MALLINCKRODT, LLC | Mallinckrodt | environmental violation | 2013 | EPA | $449,740 |
GLAXOSMITHKLINE VACCINES | GlaxoSmithKline | environmental violation | 2014 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $172,900 |
DePuy Synthes | Johnson & Johnson | environmental violation | 2019 | EPA | $51,750 |
Amgen Inc. | Amgen | environmental violation | 2007 | EPA | $24,368 |
Advanced Sterilization Products, Div of Ethicon | Johnson & Johnson | environmental violation | 2014 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $136,800 |
Genentech | Roche | environmental violation | 2023 | EPA | $158,209 |
Janssen Pharmaceutica Inc. | Johnson & Johnson | environmental violation | 2004 | EPA | $7,700 |
NOVARTIS PRODUCTS | Novartis | environmental violation | 2000 | EPA | $13,200 |
NOVARTIS CONSUMER HEALTH, INC. | Novartis | environmental violation | 2000 | EPA | $5,000 |
BRISTOL-MYERS SQUIBB COMPANY | Bristol-Myers Squibb | environmental violation | 2000 | EPA | $5,000 |
Johnson & Johnson | Johnson & Johnson | environmental violation | 2004 | EPA | $5,000 |
ETHICON ENDO SURGERY | Johnson & Johnson | aviation safety violation | 2010 | FAA | $5,500 |
ALDRICH CHEMICAL | Merck KGaA (EMD) | aviation safety violation | 2010 | FAA | $6,500 |
MILLIPORE CORPORATION | Merck KGaA (EMD) | aviation safety violation | 2010 | FAA | $15,000 |
SIGMA-ALDRICH | Merck KGaA (EMD) | aviation safety violation | 2011 | FAA | $30,000 |
SIGMA-ALDRICH INC | Merck KGaA (EMD) | aviation safety violation | 2013 | FAA | $8,000 |
SIGMA-ALDRICH | Merck KGaA (EMD) | aviation safety violation | 2013 | FAA | $11,000 |
BOEHRINGER INGELHEIM PHARMACEUTICALS | Boehringer Ingelheim | aviation safety violation | 2014 | FAA | $15,000 |
GLAXO SMITH KLINE | GlaxoSmithKline | aviation safety violation | 2014 | FAA | $59,500 |
ALDRICH CHEMICAL | Merck KGaA (EMD) | aviation safety violation | 2016 | FAA | $7,500 |
MERCK & CO. | Merck | aviation safety violation | 2015 | FAA | $65,000 |
MERCK & CO. INC. | Merck | aviation safety violation | 2015 | FAA | $65,000 |
SIGMA-ALDRICH, INC | Merck KGaA (EMD) | aviation safety violation | 2017 | FAA | $5,000 |
Advanced Sterilization Products, a division of Ethicon Inc. | Johnson & Johnson | drug or medical equipment safety violation | 2013 | FDA | $1,200,000 |
Genzyme Corporation | Sanofi | drug or medical equipment safety violation | 2015 | FDA | $32,587,439 |
McNeil-PPC Inc. | Johnson & Johnson | drug or medical equipment safety violation | 2015 | FDA | $25,000,000 |
Endo Health Solutions Inc. | Endo International | off-label or unapproved promotion of medical products | 2014 | FDA | $192,700,000 |
Johnson & Johnson | Johnson & Johnson | off-label or unapproved promotion of medical products | 2013 | FDA | $2,200,000,000 |
Wyeth Pharmaceuticals Inc. | Pfizer | off-label or unapproved promotion of medical products | 2013 | FDA | $490,900,000 |
Par Pharmaceutical Companies Inc. | Endo International | off-label or unapproved promotion of medical products | 2013 | FDA | $45,000,000 |
Pfizer Inc. | Pfizer | drug or medical equipment safety violation | 2012 | FDA | $55,000,000 |
GlaxoSmithKline LLC | GlaxoSmithKline | off-label or unapproved promotion of medical products | 2012 | FDA | $3,000,000,000 |
Abbott Laboratories Inc. | AbbVie | off-label or unapproved promotion of medical products | 2012 | FDA | $1,500,000,000 |
Cypress Pharmaceutical Inc. | Currax Pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | FDA | $2,800,000 |
Merck, Sharp & Dohme | Merck | off-label or unapproved promotion of medical products | 2011 | FDA | $950,000,000 |
Pfizer Inc. | Pfizer | off-label or unapproved promotion of medical products | 2011 | FDA | $14,500,000 |
Scios Inc. | Johnson & Johnson | off-label or unapproved promotion of medical products | 2011 | FDA | $85,000,000 |
Novo Nordisk Inc. | Novo Holdings A/S | off-label or unapproved promotion of medical products | 2011 | FDA | $25,000,000 |
UCB Inc. | UCB | off-label or unapproved promotion of medical products | 2011 | FDA | $34,000,000 |
Forest Pharmaceuticals Inc. | AbbVie | off-label or unapproved promotion of medical products | 2011 | FDA | $164,000,000 |
Elan Corporation PLC | Perrigo | off-label or unapproved promotion of medical products | 2010 | FDA | $203,000,000 |
Eisai Inc. | Eisai | off-label or unapproved promotion of medical products | 2010 | FDA | $11,000,000 |
SB Pharmco Puerto Rico Inc. | GlaxoSmithKline | drug or medical equipment safety violation | 2010 | FDA | $750,000,000 |
Novartis Pharmaceuticals Corporation | Novartis | off-label or unapproved promotion of medical products | 2010 | FDA | $422,500,000 |
Allergan Inc. | AbbVie | off-label or unapproved promotion of medical products | 2010 | FDA | $600,000,000 |
Ortho-McNeil Pharmaceutical LLC | Johnson & Johnson | off-label or unapproved promotion of medical products | 2010 | FDA | $81,000,000 |
AstraZeneca LP | AstraZeneca | off-label or unapproved promotion of medical products | 2010 | FDA | $520,000,000 |
Amgen Inc. | Amgen | off-label or unapproved promotion of medical products | 2012 | FDA | $762,000,000 |
Ranbaxy USA Inc. | Sun Pharmaceuticals | drug or medical equipment safety violation | 2013 | FDA | $500,000,000 |
Kos Pharmaceuticals | AbbVie | kickbacks and bribery | 2010 | FDA | $41,500,000 |
Warner Chilcott PLC | AbbVie | off-label or unapproved promotion of medical products | 2015 | FDA | $125,000,000 |
Shire Pharmaceuticals LLC | Takeda Pharmaceutical | off-label or unapproved promotion of medical products | 2014 | FDA | $56,500,000 |
Boehringer Ingelheim Pharmaceuticals Inc. | Boehringer Ingelheim | off-label or unapproved promotion of medical products | 2012 | FDA | $95,000,000 |
Novartis Vaccines & Diagnostics Inc. and Novartis Pharmaceuticals Corporation | Novartis | off-label or unapproved promotion of medical products | 2010 | FDA | $72,500,000 |
Pfizer Inc. | Pfizer | off-label or unapproved promotion of medical products | 2009 | FDA | $2,300,000,000 |
Eli Lilly and Company | Eli Lilly | off-label or unapproved promotion of medical products | 2009 | FDA | $1,415,000,000 |
Cephalon Inc | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2008 | FDA | $425,000,000 |
Otsuka American Pharmaceutical Inc. | Otsuka Pharmaceutical | off-label or unapproved promotion of medical products | 2008 | FDA | $4,000,000 |
Serono, S.A. | Merck KGaA (EMD) | off-label or unapproved promotion of medical products | 2005 | FDA | $704,000,000 |
Warner-Lambert | Pfizer | off-label or unapproved promotion of medical products | 2004 | FDA | $430,000,000 |
Eli Lilly and Company | Eli Lilly | off-label or unapproved promotion of medical products | 2005 | FDA | $36,000,000 |
GNC Holdings Inc. | Harbin Pharmaceutical Group | drug or medical equipment safety violation | 2016 | FDA | $2,250,000 |
InterMune Inc. | Roche | off-label or unapproved promotion of medical products | 2006 | FDA | $36,900,000 |
Wyeth-Ayerst Laboratories Division | Pfizer | drug or medical equipment safety violation | 2000 | FDA | $30,000,000 |
Morton Grove Pharmaceuticals, Inc. | Wockhardt Limited | campaign finance violation | 2007 | FEC | $9,000 |
Astellas Pharma US, Inc. | Astellas Pharma | campaign finance violation | 2022 | FEC | $7,500 |
AstraZeneca | AstraZeneca | False Claims Act and related | 2004 | FL-AG | $807,826 |
General Nutrition Corp. | Harbin Pharmaceutical Group | consumer protection violation | 2002 | FL-AG | $1,000,000 |
Purdue Pharma L.P. | Purdue Pharma | consumer protection violation | 2002 | FL-AG | $2,150,000 |
Roxane Laboratories, Inc. | Hikma Pharmaceuticals | False Claims Act and related | 2009 | FL-AG | $8,500,000 |
Endo Health Solutions Inc. and Endo Pharmaceuticals Inc. | Endo International | off-label or unapproved promotion of medical products | 2022 | FL-AG | $65,000,000 |
Teva Pharmaceutical Industries | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2022 | FL-AG | $278,826,499 |
Allergan Ltd. et al. | AbbVie | off-label or unapproved promotion of medical products | 2022 | FL-AG | $134,200,000 |
Endo Health Solutions and Endo Pharmaceuticals | Endo International | off-label or unapproved promotion of medical products | 2022 | FL-AG | $65,000,000 |
VISTAKON | Johnson & Johnson | environmental violation | 2005 | FL-DEP | $9,771 |
ANDRX PHARMACEUTICALS, INC. | Teva Pharmaceutical Industries | environmental violation | 2001 | FL-DEP | $15,000 |
CAMBRIDGE MAJOR LABORATORIES INC | Alcami | motor vehicle safety violation | 2006 | FMCSA | $18,560 |
EMD CHEMICALS INCORPORATED | Merck KGaA (EMD) | motor vehicle safety violation | 2006 | FMCSA | $7,614 |
CAMBRIDGE MAJOR LABORATORIES INC | Alcami | motor vehicle safety violation | 2005 | FMCSA | $15,820 |
EMD CHEMICALS INCORPORATED | Merck KGaA (EMD) | motor vehicle safety violation | 2004 | FMCSA | $13,170 |
Cody Laboratories Inc | Lannett Co. | motor vehicle safety violation | 2018 | FMCSA | $8,510 |